These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 38941291)
1. Recombinant Art v4.01 protein produces immunological tolerance by subcutaneous immunotherapy in a wormwood pollen-driven allergic asthma female mouse model. Wang T; Chi J; Li Z; Zhang Y; Wang Y; Ding M; Zhou B; Gui J; Li Q PLoS One; 2024; 19(6):e0280418. PubMed ID: 38941291 [TBL] [Abstract][Full Text] [Related]
2. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma. Hesse L; Petersen AH; Nawijn MC Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602 [TBL] [Abstract][Full Text] [Related]
3. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma. Hesse L; Nawijn MC Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043 [TBL] [Abstract][Full Text] [Related]
4. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma. Hesse L; Brouwer U; Petersen AH; Gras R; Bosman L; Brimnes J; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757 [TBL] [Abstract][Full Text] [Related]
5. High dose vitamin D Hesse L; van Ieperen N; Petersen AH; Elberink JNGO; van Oosterhout AJM; Nawijn MC Sci Rep; 2020 Nov; 10(1):20876. PubMed ID: 33257771 [TBL] [Abstract][Full Text] [Related]
6. Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores. Hessenberger M; Weiss R; Weinberger EE; Boehler C; Thalhamer J; Scheiblhofer S Vaccine; 2013 Jul; 31(34):3427-34. PubMed ID: 23273971 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Novel Adjuvanted Vaccine for Ultrashort Regimen Therapy of Tabynov K; Babayeva M; Nurpeisov T; Fomin G; Nurpeisov T; Saltabayeva U; Renu S; Renukaradhya GJ; Petrovsky N; Tabynov K Front Immunol; 2022; 13():828690. PubMed ID: 35371056 [TBL] [Abstract][Full Text] [Related]
8. An epicutaneous therapeutic pollen-allergen extract delivery system in an allergic rhinitis mouse model: based on allergen loading on DC-specific aptamers conjugated nanogolds. Pordel S; Haghnavaz N; Rezaee M; Shobeiri SS; Ansari B; Dashti M; Moghadam M; Khorrami M; Sankian M Immunol Res; 2024 Jun; 72(3):460-475. PubMed ID: 38091227 [TBL] [Abstract][Full Text] [Related]
9. [Immunological characteristics of the recombinant major pollen allergen pTSX2 of Humulus scandens]. Wu Y; Sun X; Li M; Liu Y; Wang G; Lu J Nan Fang Yi Ke Da Xue Xue Bao; 2012 Oct; 32(10):1431-4. PubMed ID: 23076178 [TBL] [Abstract][Full Text] [Related]
10. Effects of Caryota mitis profilin-loaded PLGA nanoparticles in a murine model of allergic asthma. Xiao X; Zeng X; Zhang X; Ma L; Liu X; Yu H; Mei L; Liu Z Int J Nanomedicine; 2013; 8():4553-62. PubMed ID: 24376349 [TBL] [Abstract][Full Text] [Related]
12. A recombinant Babayeva M; Tabynov K; Nurpeisov T; Fomin G; Renukaradhya GJ; Petrovsky N; Tabynov K Front Immunol; 2022; 13():983621. PubMed ID: 36439113 [TBL] [Abstract][Full Text] [Related]
13. Birch pollen-specific subcutaneous immunotherapy reduces ILC2 frequency but does not suppress IL-33 in mice. van Rijt LS; Logiantara A; Canbaz D; van Ree R Clin Exp Allergy; 2018 Nov; 48(11):1402-1411. PubMed ID: 30126007 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Rossi RE; Monasterolo G Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445 [TBL] [Abstract][Full Text] [Related]
15. IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. Wild JS; Sigounas A; Sur N; Siddiqui MS; Alam R; Kurimoto M; Sur S J Immunol; 2000 Mar; 164(5):2701-10. PubMed ID: 10679111 [TBL] [Abstract][Full Text] [Related]
16. Detection of pan-allergens in commercial pollen extracts for allergen immunotherapy. Asero R; Mistrello G; Amato S Ann Allergy Asthma Immunol; 2016 Aug; 117(2):180-5. PubMed ID: 27238577 [TBL] [Abstract][Full Text] [Related]
17. 1,25-dihydroxyvitamin D₃ pretreatment enhances the efficacy of allergen immunotherapy in a mouse allergic asthma model. Ma JX; Xia JB; Cheng XM; Wang CZ Chin Med J (Engl); 2010 Dec; 123(24):3591-6. PubMed ID: 22166637 [TBL] [Abstract][Full Text] [Related]
18. Epicutaneous immunotherapy with a hypoallergenic Bet v 1 suppresses allergic asthma in a murine model. Siebeneicher S; Reuter S; Wangorsch A; Krause M; Foetisch K; Heinz A; Naito S; Reuter A; Taube C; Vieths S; Scheurer S; Toda M Allergy; 2015 Dec; 70(12):1559-68. PubMed ID: 26304061 [TBL] [Abstract][Full Text] [Related]
19. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract. Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262 [TBL] [Abstract][Full Text] [Related]
20. Oral administration of allergen extracts from mugwort pollen desensitizes specific allergen-induced allergy in mice. Ma WJ; Bao MJ; Zhu JP; Yao HY; Xie YC; Guan Y; Li FF; Dong XW; Zheng YM; Xie QM Vaccine; 2012 Feb; 30(8):1437-44. PubMed ID: 22240342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]